Carboprost Tromethamine Solution
Product Images NDC 70594-112

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carboprost Tromethamine (NDC 70594-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carboprost 01)

Chemical Structure (Carboprost 01)
Chemical structure of carboprost tromethamine showing its molecular arrangement, including hydroxyl groups, carbon chains, and associated tromethamine moiety.*
FDA Label Image

Principal Display Panel (250 mcg/mL Vial Carton)

Principal Display Panel (250 mcg/mL Vial Carton)
Carton labeling for Carboprost Tromethamine Injection, USP 250 mcg/mL solution for intramuscular use. The package contains 10 single-dose vials of 1 mL each. Distributed by Xellia Pharmaceuticals USA LLC, the label includes storage instructions and a note to discard unused portions. Made in India and manufactured by Stelis Biopharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.